azathioprine has been researched along with Toxoplasmosis, Cerebral in 2 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Toxoplasmosis, Cerebral: Infections of the BRAIN caused by the protozoan TOXOPLASMA gondii that primarily arise in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES (see also AIDS-RELATED OPPORTUNISTIC INFECTIONS). The infection may involve the brain diffusely or form discrete abscesses. Clinical manifestations include SEIZURES, altered mentation, headache, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. (From Joynt, Clinical Neurology, 1998, Ch27, pp41-3)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We observed a severe case of cerebral toxoplasmosis in a 22-year-old woman diagnosed with dermatomyositis in 2016 in Venezuela, and treated with rituximab and azathioprine." | 8.02 | Cerebral toxoplasmosis associated with treatment with rituximab, azathioprine and prednisone for dermatomyositis. ( Castaño-Amores, C; Nieto-Gómez, P, 2021) |
| "We observed a severe case of cerebral toxoplasmosis in a 22-year-old woman diagnosed with dermatomyositis in 2016 in Venezuela, and treated with rituximab and azathioprine." | 4.02 | Cerebral toxoplasmosis associated with treatment with rituximab, azathioprine and prednisone for dermatomyositis. ( Castaño-Amores, C; Nieto-Gómez, P, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castaño-Amores, C | 1 |
| Nieto-Gómez, P | 1 |
| Assimakopoulos, SF | 1 |
| Stamouli, V | 1 |
| Dimitropoulou, D | 1 |
| Spiliopoulou, A | 1 |
| Panos, G | 1 |
| Anastassiou, ED | 1 |
| Marangos, M | 1 |
| Spiliopoulou, I | 1 |
2 other studies available for azathioprine and Toxoplasmosis, Cerebral
| Article | Year |
|---|---|
Cerebral toxoplasmosis associated with treatment with rituximab, azathioprine and prednisone for dermatomyositis.
Topics: Adult; Azathioprine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Prednisone; Rituxim | 2021 |
Toxoplasma gondii meningoencephalitis without cerebral MRI findings in a patient with ulcerative colitis under immunosuppressive treatment.
Topics: Adult; Azathioprine; Brain; Cerebrospinal Fluid; Colitis, Ulcerative; Female; Glucocorticoids; Human | 2015 |